![Rashieda Gluck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rashieda Gluck
Technik-/Wissenschafts-/F&E-Leiter bei
DIANTHUS THERAPEUTICS, INC.
Profil
Currently, Rashieda Gluck is Head-Clinical Development Operations at Dianthus Therapeutics, Inc. since 2023.
Formerly, served as Independent Director at Kane Biotech, Inc., Vice President-Clinical Operations at Aspreva Pharmaceuticals Corp., Senior Vice President-Global Clinical Operations at Aurinia Pharmaceuticals, Inc. from 2018 to 2022, Vice President-Clinical Operations at Qu Biologics, Inc. from 2013 to 2015, and VP & Head-Global Clinical Pharmaceuticals at Vifor Pharma Management AG from 2008 to 2013.
Education includes undergraduate studies at the University of British Columbia.
Aktive Positionen von Rashieda Gluck
| Unternehmen | Position | Beginn |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.09.2023 |
Ehemalige bekannte Positionen von Rashieda Gluck
| Unternehmen | Position | Ende |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2022 |
Qu Biologics, Inc.
 Qu Biologics, Inc. BiotechnologyHealth Technology Develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2015 |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2013 |
| KANE BIOTECH INC. | Direktor/Vorstandsmitglied | - |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Rashieda Gluck
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
30
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Kane Biotech, Inc.
 Kane Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that manufactures animal health oral care products | Commercial Services |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer | Health Technology |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
Wählen Sie MarketScreener 
